In addition, within the context of obesity-associated IR, BITC enhanced insulin sensitivity in a Nrf2-dependent manner, lowering hyperglycemia in vivo and in vitro and potentially protecting against obesity-related T2D [89]. This evidence concerns the gene NFE2L2 and type 2 diabetes mellitus.